West Coast Private Equity Firm

Executive Summary

A West Coast Private Equity Firm engaged Asbury HealthTech Partners to evaluate a potential acquisition of a radiology IT company undergoing a major platform transition. Asbury conducted a deep technical and operational review focused on product maturity, scalability, and go-to-market execution. The findings surfaced both strong financial fundamentals and significant risks related to migration readiness and enterprise fit, informing the firm's investment decision.

The Challenge

The West Coast Private Equity Firm required a comprehensive assessment of a healthcare SaaS vendor transitioning from a legacy platform to a modern, cloud-native solution. Key challenges included:

  • Migration Complexity: Incomplete features and tooling raised concerns about the ease and success of customer transition.
  • Platform Scalability: Maintaining dual platforms was contributing to technical debt and limiting development velocity.
  • Competitive Positioning: Lack of clear product differentiation in a crowded radiology IT market.
  • Sales Execution: Unclear metrics around sales efficiency and potential misalignment of incentives.
  • Customer Risk: Migration-related friction and support limitations posed churn threats, especially among SMB clients.

Our Solution

Asbury delivered a structured diligence process focused on identifying technical, operational, and strategic risks. Our approach included:

  • Infrastructure & Architecture Review: Assessed codebase integrity, cloud performance, and scalability.
  • Product Gap Identification: Mapped out missing capabilities critical to enterprise adoption.
  • Customer Transition Modeling: Analyzed adoption friction, support burden, and retention risk during platform migration.
  • GTM & Sales Analysis: Evaluated international expansion strategy, partner/channel dependencies, and rep productivity.
  • Security & Compliance Audit: Flagged issues related to PHI protection, breach history, and regulatory posture.

Results & Impact

Asbury's work enabled the West Coast Private Equity Firm to make an evidence-based investment decision, supported by:

  • Identification of 6 core risk areas across product, platform, and GTM functions
  • Recommendations for roadmap validation and third-party technical audit
  • 25+ targeted diligence questions for deeper discovery across functional areas
  • Modeling of customer churn risk tied to migration complexity
  • Negotiation leverage informed by technical and operational realities

Testimonials

"Asbury HealthTech brought clarity to a highly technical and nuanced investment opportunity. Lee's team delivered high-value insights we wouldn't have uncovered otherwise which was absolutely critical to our diligence process."

— Managing Director, West Coast Private Equity Firm